Regional News

Don't miss our other news sources!

Kyma Technologies Lands $2.6 Million Funding

Kyma Technologies, an RTP-based semiconductor materials startup, has landed $2.6 million in its first round of venture funding. The money will be used to finance the company's efforts to complete research and development and to generate its first revenues. Chief Executive Ed Pupa said the funding came from venture and strategic investors, but would not disclose from whom. Kyma was formed out of technology licensed from North Carolina State University in 1998. www.kymatech.com

[return to top of EntreNews]

DecisionPoint International Announces Two Transactions

DecisionPoint International, a boutique investment bank, announced the closure of two Charlotte-based transactions. Pomeroy Computer Resources acquired, and will merge together, Ballantyne Consulting Group and System 5 Technologies, Inc. to create an expanded IT Services platform. Pomeroy provides complete IT integration solutions including comprehensive services, procurement and financial offerings. www.decisionpointint.com

[return to top of EntreNews]

AaiPharma Unit Purchases London Product Line for $100 Million

AaiPharma of Wilmington recently announced that its NeoSan Pharmaceuticals business unit has completed an approximately $100 million purchase of injectable nutrition products from AstraZeneca AB, an affiliate of AstraZeneca PLC (NYSE: AZN) of London. Under the terms of the deal, NeoSan will make payments totaling up to $100 million over the next three years for the product line, which target patients who are unable to take oral nutrition. The acquired product line is the first in NeoSan's brand portfolio. NeoSan will use its recently hired staff of sales and marketing professionals to promote the product line to hospitals, the home-care market, extended-care and nursing facilities, HIV facilities and addiction-treatment centers. www.aaipharma.com

[return to top of EntreNews]

North Carolina Biotechnology Center CEO to Retire

Charles E. Hamner, CEO and president of the North Carolina Biotechnology Center, a nonprofit corporation funded by the state's general assembly, is expected to retire on March 31, 2002. As part of its effort to develop the state's biotechnology industry, the organization established Eno River Capital, an evergreen fund that invests in biotechnology companies. North Carolina Biotechnology Center will continue to make low-interest loans to biotech firms, though it takes no equity positions. The firm is conducting a search for Hamner's replacement. www.ncbiotech.org

[return to top of EntreNews]

Analytical Sciences Executive to Co-Chair National AIDS Committee


A top executive of Analytical Sciences, Inc. (ASI), a Durham-based contract research organization, has been named co-chair of the national HIV/AIDS Advisory Committee (HAAC) of the Health Resources and Services Administration (HRSA). Jesse Milan, Jr., JD, vice president and director of the company's health communications division, is a renowned subject expert on HIV/AIDS. He will serve as committee co-chair with Dr. Joseph O'Neill. Milan has served as a member of HAAC since July 1999 and was nominated to serve through June 30, 2003. www.asciences.com

[return to top of EntreNews]

Boston Globe

Spotlights RTP

A September 12 Boston Globe article spotlighted the Research Triangle and four other high-tech hubs on their economic prospectives. The Globe's Anthony Shadid wrote about RTP: "This area is often credited with doing it right. It built on the capital of its research universities -- University of North Carolina, North Carolina State and Duke -- and developed the remarkably successful 7,000-acre Research Triangle Park, an engine for high-tech growth." The article cited the economic hangover that RTP and other technology hubs are experiencing and then put a positive spin on the region. "North Carolina still boasts affordable housing, relatively reasonable traffic, warm weather and, as everyone points out, universities churning out top-flight graduates. 'In Boston, you've got MIT and Harvard,' [Vivek Wadhwa, Relativity Technologies] says, 'But you've got 10 times as many businesses going after the students. Here you've got great universities but there's not that much demand.' " To read the full article, visit http://digitalmass.boston.com/special_sections/2001/future/leaders.html.

[return to top of EntreNews]

Paradigm Genetics Reaches Milestone

Research Triangle Park-based Paradigm Genetics (Nasdaq: PDGM), a functional genomics company, announced it has exceeded the fifth consecutive milestone in its commercial partnership with Monsanto Company (NYSE: MON). Paradigm will receive an undisclosed accelerated milestone payment for this accomplishment. Paradigm also announced that Monsanto has amended the commercial partnership agreement by eliminating its termination option in exchange for broader rights under the agreement. www.paragen.com

[return to top of EntreNews]

Events Update
October 4th — CED Information Session for Prospective Members

October 5th — CED Executive Series: Improving Your Bottom Line

October 9th — CED's 2001 Annual Meeting

October 10th — CED Capital Connection Information Session

October 16th - 17th — SEBIO - the Third Annual Southeastern Bio Investors Forum, Birmingham, AL

[return to top of EntreNews]